Skip to content

One-year Mortality After Surgery and Low Bispectral Index

One-year Mortality According to the Method of Total Intravenous Anesthesia. A Prospective, Randomized and Multicenter Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01198639
Acronym
ELA
Enrollment
2044
Registered
2010-09-10
Start date
2010-09-13
Completion date
2015-02-20
Last updated
2018-02-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

General Anesthesia

Brief summary

A correlation between deep anesthesia (defined as time with Bispectral Index (BIS) lower than 45) and death within 1 yr after surgery has previously been reported. In order to confirm or refute these findings, the investigators have designed a study which compares two methods of administration for total intravenous anesthesia (propofol and remifentanil): * manual administration: the anesthesiologists are instructed to maintain the BIS value between 40 and 60. * closed loop administration: an algorithm is used to maintain the BIS value between 40 and 60. Based on previous studies, the amount of time that BIS is maintained above 40 is greater when anesthetics agents are administered using closed loop compared with manual administration.

Interventions

DEVICEmanual administration of iv anesthetics (propofol and remifentanil) using the Toolbox platform

the anesthesiologists are instructed to maintain the BIS values between 40 and 60 throughout anesthesia using target controlled infusion method

DEVICEclosed-loop administration of iv anesthetics (propofol and remifentanil) using the Toolbox platform

an algorithm is used to maintain automatically the BIS values between 40 and 60

Sponsors

Hopital Foch
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
50 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

* American Society of Anesthesiology patient classification status I, II and III * patients aged between 50 and 85 years old * born in France * surgical procedures lasting more than one hour

Exclusion criteria

* American Society of Anesthesiology patient classification status IV * patients born out of France * pace-maker * surgical procedure on the skull or avoiding an adequate positioning of the bispectral index electrode dementia, history of central nervous system disease (tumor, vascular event, Parkinson disease, ...) * psychiatric illness (severe depression or psychosis), patients receiving a psychotropic treatment * anesthesia performed during the year before inclusion in this study except for diagnostic procedures * allergy to propofol, soja, peanuts, or to sufentanil, remifentanil, or morphine, to a myorelaxant or to an excipient, * hypersensibility to sufentanil, to remifentanil, or to other derivate of fentanyl

Design outcomes

Primary

MeasureTime frame
Mortality rate during the first year following anesthesiaone year after anesthesia

Secondary

MeasureTime frame
intraoperative awarenessone month postoperatively
patients' satisfaction in the postanesthesia care unit (nausea, vomiting, shivering)end of the stay in the postanesthesia care unit
postoperative complication during the hospital stay (ancillary study)one month after anesthesia
conduct of anesthesia (duration of anesthesia with bispectral index < 45, bispectral index < 40, bispectral index > 60, bispectral index > 65, and burst suppression ratio)end of anesthesia
relation between patients' characteristics and mortality rate during the first year following anesthesiaone year after anesthesia
intraoperative parameters, notably hemodynamic parameters, and their relation between them and mortality rate during the first year following anesthesiaone year after anesthesia
in-hospital and one month mortalityone year after anesthesia
major medical events during the first year following anesthesiaone year after anesthesia

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 5, 2026